Skip to main content
letter
. 2024 Oct 31;82:197. doi: 10.1186/s13690-024-01427-w

Fig. 1.

Fig. 1

(a) Annual evolution in the population-weighted overall antibiotic consumption (J01) in all 28 EU/EEA countries (Supplementary table S1). (b) Seasonal evolution in the population-weighted overall antibiotic consumption (J01) in 16 countries reporting quarterly data (Supplementary table S1). (c) Annual evolution in the population-weighted consumption of penicillins (J01C), macrolides, lincosamides and streptogramins (J01F) and other beta-lactam antibacterials (J01D) in all 28 EU/EEA countries (Supplementary table S1). (d) Seasonal evolution in the population-weighted consumption of penicillins (J01C), macrolides, lincosamides and streptogramins (J01F) and other beta-lactam antibacterials (J01D) in 16 countries reporting quarterly data (Supplementary table S1). DID: defined daily doses (DDD) per 1000 inhabitants per day